Risk factors

Kestra Medical Technologies (KMTS) risk factors

Item 1A of every Kestra Medical Technologies, Ltd. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open KMTS in Gloom →
Kestra Medical Technologies' chart, financials and news, free in your browser.Open KMTS in Gloom →
  • FY2026 10-K risk factors
    81 risks80 new91 dropped1 reworded

    IPO and secondary offering produced $215.8 million of net proceeds and increased interest income by $5.2 million.

    Filed Jul 14, 2026
  • FY2025 10-K risk factors
    92 risks

    Kestra Medical Technologies faces intense competition in the wearable cardioverter defibrillator market dominated by ZOLL's LifeVest and new adhesive-based alternatives.

    Filed Jul 17, 2025